(ATTN: ADDS bond yields at bottom, photo)
SEOUL, June 4 (Yonhap) -- South Korean shares ended higher Monday as an upbeat U.S. jobs report and revived hopes for a U.S.-North Korea summit boosted investor sentiment, analysts said. The Korean won rose against the U.S. dollar.
The benchmark Korean Stock Price Index (KOSPI) added 8.8 points, or 0.36 percent, to finish at 2,447.76. Trade volume was moderate at 433.24 million shares worth 7.56 trillion won (US$7.05 billion), with gainers outnumbering losers 433 to 407.
Local stocks rose as strong U.S. jobs data bolstered optimism in the world's largest economy, though investors remain concerned about the possible impact of a trade war between the U.S. and China.
"Signs of recovery in the U.S. economy and hopes for a gradual interest rate hike are positive factors for Korean stocks," Seo Sang-young, an analyst at Kiwoom Securities, said. "Investors are also wary of trade disputes between U.S. and China as the latest round of trade talks ended without settlement."
Foreigners and institutions scooped up a net 18.37 billion won and 55 billion won, respectively, while retail investors dumped 91.86 billion won worth of shares more than they bought.
Shares related to North Korea increased on hopes for a revival of cross-border projects as preparations continued for U.S. President Donald Trump's summit with North Korean leader Kim Jong-un in Singapore.
Top steelmaker POSCO rose 3.83 percent to 352,500 won, and train manufacturer Hyundai Rotem gained 0.75 percent to 40,550 won.
Auto shares also traded higher, with leading carmaker Hyundai Motor advancing a solid 2.14 percent to 143,000 won and its corporate cousin Kia Motors jumping 5.8 percent to 33,750 won.
Tech firms slumped after Chinese media reported that Beijing was investigating Chinese branch offices of Samsung Electronics and SK hynix amid continued price increases for memory chips.
Market kingpin Samsung Electronics fell 0.39 percent to 51,100 won, and SK hynix, a major chipmaker, retreated 1.75 percent to 89,800 won.
Bio shares were down.
Pharmaceutical giant Celltrion lost 2.56 percent to 266,500 won, and Samsung Biologics, the healthcare unit of Samsung Group, tumbled 7.2 percent 419,000 won.
The South Korean currency closed at 1,071.9 won against the U.S. dollar, up 3.1 won from the previous session's close.
Bond prices, which move inversely to yields, ended lower. The yield on three-year Treasurys rose 2 basis points to 2.213 percent, and the return on benchmark five-year government bonds added 2.5 basis points to 2.504 percent.
Japanese Embassy sends back Moon's New Year gift over Dokdo image box
(LEAD) Daily cases bounce to over 7,000 for 1st time in month amid omicron woes
23 shippers fined 96.2 bln won for collusion on freight rates
(2nd LD) Daily cases back above 4,000 amid omicron woes
(URGENT) S. Korea reports 5,805 new COVID-19 cases; critical cases at 532: KDCA
U.S., 7 other nations urge full implementation of N. Korea sanctions
(LEAD) Thousands of Buddhist monks hold rally to demand apology from president for 'anti-Buddhist bias'
'Kim Ji-young, Born 1982,' most-sold S. Korean literary book overseas
(3rd LD) N. Korea says it confirmed accuracy of tactical guided missiles in test-firing
(LEAD) Daily cases jump to over 5,000 for 1st time in 20 days amid omicron woes
(LEAD) Moon calls for swift shift to new response measures to cope with omicron
(LEAD) New COVID-19 cases above 7,000 for 3rd day amid persistent omicron fears
(4th LD) S. Korea likely to report highest-ever new cases amid accelerating omicron spread
S. Korean romance TV series gain popularity on Netflix
Biz hour curbs cause largest drop in in-person spending among all measures: BOK report